Health2023 saw a cautious hope for Alzheimer's treatment but doubts remain The US approved lecanemab to slow cognitive decline among people with early Alzheimer's, but not everyone is convinced the drug has that big of an impact – not to mention concerns over its safety and practicality ¿ìè¶ÌÊÓÆµ
PhysicsLK-99 superconductor mania swept the internet for a few weeks in 2023 The promise of a material that could revolutionise the way we use electricity captured imaginations on social media, which also helped researchers quickly determine that LK-99 wasn't what it seemed ¿ìè¶ÌÊÓÆµ